Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

EVTCY:US

8.1900 USD 0.3100 3.65%

As of 20:10:03 ET on 05/28/2015.

Snapshot for Evotec AG (EVTCY)

Open: 8.2500 Day's Range: 8.1900 - 8.2500 Volume: 1,500
Previous Close: 8.5000 52wk Range: 6.2600 - 11.4420 1-Yr Rtn: -17.02%

Stock Chart for EVTCY

No chart data available.
  • EVTCY:US 8.1900
  • 1D
  • 1M
  • 1Y
8.5000
Interactive EVTCY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVTCY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 539.46
Shares Outstanding (M) 65.87
30 Day Average Volume 554
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVTCY

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVTCY

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Werner LanthalerCEO/Investor RelationsColin BondCFO/Member-Mgmt Board
Mario PolywkaCOO/Member-Mgmt BdCord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVTCY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil